Life expectancy low in MEN1 duodenopancreatic neuroendocrine tumor liver metastases

15 Mar 2017


Half of patients with multiple endocrine neoplasia type 1 (MEN1), who developed duodenopancreatic neuroendocrine tumor liver metastases died within 10 years, according to a study in Endocrine Practice.

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story